by Neoteryx | 4 min read
If you are a researcher seeking to learn more about microsampling and how it works, you can find many resources to help you on the Neoteryx website. Are you wondering …
Read Storyby Neoteryx | 2 min read
Remote clinical trials can help overcome the traditional obstacles and interruptions in clinical studies. The COVID-19 pandemic provided a new opportunity to pursue the remote approach to research. Remote specimen collection …
Read Storyby Neoteryx | 4 min read
Clinical trials are vital to advancing medical science, but they face many stumbling blocks. New technology has given researchers the ability to take clinical trials outside the trial site and …
Read Storyby Neoteryx | 5 min read
Organizing a clinical trial is no easy feat. Researchers must recruit a group of willing participants. The participants must meet the study criteria and be prepared to comply with all …
Read Storyby Neoteryx | 2 min read
Virtual clinical trials (remote trials) are a relatively new concept that has great promise, but has yet to be fully realized in clinical research studies. The approach utilizes technologies like …
Read Storyby Neoteryx | 3 min read
Alzheimer’s disease, the most common type of dementia, causes cognitive decline, mood and behavior changes, and memory loss. The leading cause of Alzheimer's disease (AD) is the accumulation of the 42-amino-acid-long …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.